Completed
Topics
Coccidioidomycosis, or “Valley fever”, is a fungal disease caused by inhalation of Coccidioides spores from the soil. This fungus, generally found in arid environments in the southwestern US and Latin America, can cause severe debilitating, and sometimes fatal, illness in humans and animals. Despite the public health burden of this disease, a lack of research investment has led to limited options for treatment and control. This workshop will convene experts to discuss the epidemiology and public health impact of Valley Fever, as well as opportunities to facilitate development of diagnostics, therapeutics, and vaccines.
Featured publication
Workshop_in_brief
·2023
Coccidioidomycosis, or "Valley fever," is a fungal disease caused by inhalation of Coccidioides spores from the soil. This fungus, generally found in arid environments in the southwestern U.S. and Latin America, can cause severe, debilitating, and sometimes fatal illness in humans and animals. Despi...
View details
Description
A planning committee of the National Academies of Sciences, Engineering, and Medicine will organize a public workshop to review the epidemiology of coccidioidomycosis (Valley Fever), its impact on populations, and currently available diagnostic and treatment options. The workshop will explore prospects for control of the disease through vaccination.
Specifically, the workshop will feature invited presentations and discussions on the following topics:
- Overview of valley fever in human and animal populations to include current surveillance programs and diagnostic and treatment options;
- Epidemiology of valley fever in the United States and throughout the Americas;
- Impact of climate change on persistence and spread of Coccidioides;
- Risk of disease by occupation, ethnicity, and immunogenetic susceptibility and impact on endemic communities;
- Economic impact of valley fever;
- Immunology of valley fever and potential prevention through vaccination;
- Potential vaccine platforms and current animal models;
- Strengthening research and research partnerships on overall fungal diseases for therapeutics or vaccine development;
- Regulatory pathways for a fungal disease vaccine;
- Vaccine acceptance and communication.
Speakers and discussants will contribute perspectives from academia, local, national and international public health, pharmaceutical industries, and government regulatory institutions. The planning committee will organize the workshop, select and invite speakers and discussants, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.
Collaborators
Committee
Chair
Member
Member
Member
Member
Member
Member
Member
Elizabeth (Liz) Ashby
Staff Officer
Sponsors
California Health Care Foundation
Department of Health and Human Services
Private: For Profit
Private: Non Profit
Staff
Julie Pavlin
Lead
Liz Ashby
Lead
Julie Liao
Claire Biffl
Justin Hammerberg